Dose-dense Paclitaxel With Carboplatin for Advanced Ovarian Cancer: Is It a Feasible and Efficacious Treatment Alternative for Indian Women?

被引：0
|
作者：
Bajpai, J. [1 ]
Poladia, B. [1 ]
Susan, D. [1 ]
Shylasree, T. S. [1 ]
Gupta, S. [1 ]
Ghosh, J. [1 ]
Maheshwari, A. [1 ]
Menon, S. [1 ]
Kerkar, R. A. [1 ]
机构：
[1] Tata Mem Hosp, Mumbai, Maharashtra, India
来源：
CLINICAL ONCOLOGY | 2017年 / 29卷 / 09期
关键词：
D O I：
10.1016/j.clon.2017.03.007
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：638 / 638
页数：1
相关论文
共 50 条
  • [1] Dose-Dense Paclitaxel With Carboplatin for Advanced Ovarian Cancer: A Feasible Treatment Alternative
    Glaze, Sarah
    Teitelbaum, Lisa
    Chu, Pamela
    Ghatage, Prafull
    Nation, Jill
    Nelson, Gregg
    JOURNAL OF OBSTETRICS AND GYNAECOLOGY CANADA, 2013, 35 (01) : 61 - 67
  • [2] Dose-dense paclitaxel for advanced ovarian cancer
    Zeng, Yue-Can
    Wu, Rong
    Xu, Zhao-Guo
    Chi, Feng
    LANCET, 2010, 375 (9711): : 280 - 281
  • [3] Dose-dense Paclitaxel in Advanced Ovarian Cancer
    Kumar, A.
    Hoskins, P. J.
    Tinker, A. V.
    CLINICAL ONCOLOGY, 2015, 27 (01) : 40 - 47
  • [4] Heterogeneous treatment effect of dose-dense paclitaxel plus carboplatin therapy for advanced ovarian cancer
    Taguchi, Ayumi
    Kato, Kosuke
    Furusawa, Akiko
    Hara, Konan
    Sone, Kenbun
    Yamada, Kyosuke
    Kajiyama, Hiroaki
    Shimada, Muneaki
    Okamoto, Aikou
    INTERNATIONAL JOURNAL OF CANCER, 2024, 155 (06) : 1068 - 1077
  • [5] Dose-dense paclitaxel for advanced ovarian cancer Reply
    Katsumato, Noriyuki
    LANCET, 2010, 375 (9711): : 281 - 281
  • [6] Bevacizumab with dose-dense paclitaxel/carboplatin as first-line chemotherapy for advanced ovarian cancer
    Zhang, Li
    Zhou, Qi
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2018, 837 : 64 - 71
  • [7] Treatment Tolerance and Side Effects of Intraperitoneal Carboplatin and Dose-Dense Intravenous Paclitaxel in Ovarian Cancer
    Bisch, Steven P.
    Sugimoto, Akira
    Prefontaine, Michel
    Bertrand, Monique
    Gawlik, Christine
    Welch, Stephen
    McGee, Jacob
    JOURNAL OF OBSTETRICS AND GYNAECOLOGY CANADA, 2018, 40 (10) : 1283 - +
  • [8] The "Leuven" dose-dense paclitaxel/carboplatin regimen in patients with recurrent ovarian cancer
    Cadron, Isabelle
    Leunen, Karin
    Amant, Frederic
    Van Gorp, Toon
    Neven, Patrick
    Vergote, Ignace
    GYNECOLOGIC ONCOLOGY, 2007, 106 (02) : 354 - 361
  • [9] DOSE-DENSE WEEKLY PACLITAXEL AND CARBOPLATIN IS MORE COST-EFFECTIVE THAN BEVACIZUMAB PLUS TRIWEEKLY PACLITAXEL AND CARBOPLATIN FOR THE PRIMARY TREATMENT OF ADVANCED OVARIAN CANCER
    Harano, K.
    Shiroiwa, T.
    Watanabe, M.
    Suzuki, K.
    Fukuda, T.
    Watanabe, S.
    Katsumata, N.
    ANNALS OF ONCOLOGY, 2012, 23 : 320 - 321
  • [10] Dose-dense weekly paclitaxel and carboplatin compared with conventional paclitaxel and carboplatin treatment for stage II-IV ovarian cancer patients
    Du, Zhenhua
    Ma, Xiaolin
    BANGLADESH JOURNAL OF PHARMACOLOGY, 2015, 10 (03) : 489 - 493
12345